WakeNbake - We do things different now.
All viewers ages 18 and up, please! I had som people bring up some genetics that came from bagseed in the past. My theory is that, it had to to with there not being all the access to info, and genetics, back then. Now we all can get seeds from the best breeders in the world. Aswell as info on everything cannabis grow related. Aswell as now the herb form 3 wrold countrys, isnt as popular in our market. So when we get herb with seeds, the chances of the pollen coming from a ture male, are way lower. In 3rd world countrys the farmers plant from seed, in most cases. So they have to cull out males. In the US we tipicly grow from proven female clones. So when we have pollen in our room, or field, it most likly came from a hermie. Theirfor the bagseed is not f1, or f anythign for that matter. They are IBL #39;s, withc are extreemly likley to hermie.From:Bret1MaverickViews:321 55ratingsTime:19:55More inEntertainment

The rest is here:
WakeNbake - We do things different now. - Video

Recommendation and review posted by Bethany Smith

Coast to Coast AM July 09 2012 American Genes
Coast to Coast AM is a North American (US and Canada) late-night radio talk show that deals with a variety of topics, but most frequently ones that relate to either the paranormal or conspiracy theories. The program currently airs seven nights a week 1:05 am -- 5:00 am Eastern Time (10:05 pm -- 2:00 am Pacific Time). Originally created and hosted by Art Bell, as of 2012 the program is hosted on most nights by George Noory. According to estimates by Talkers Magazine, Coast to Coast AM draws approximately 3 million listeners, making it the most listened-to program in its time slot Format and subject matter The Coast to Coast AM format consists of a combination of live callers and long format interviews. The subject matter covers unusual topics and is full of personal stories related to callers. While program content is often focused on paranormal and fringe subjects, sometimes world class scientists such as Michio Kaku and Brian Greene are featured in long format interviews. Topics discussed include the Near-death experience, climate change, cosmology, quantum physics, remote viewing, hauntings, contact with extraterrestrials, psychic reading, metaphysics, conspiracy theories, Area 51, crop circles, cryptozoology, Bigfoot, the Hollow Earth hypothesis, and science fiction literature, among others. Since the September 11, 2001 attacks, the events of that day (as well as alternate theories surrounding them) and current US counter-terrorism strategy have also become frequent ...From:C2CVAULTViews:0 0ratingsTime:02:32:25More inEducation

More here:
Coast to Coast AM July 09 2012 American Genes - Video

Recommendation and review posted by Bethany Smith

The Man That Killed 2 Alien Greys (Phil Schneider)
Poor Video Quality, But there #39;s no need to see ,Just Listen. Phil Schneider, one of three people to survive the 1979 fire fight between the large Greys , US intelligence and military at the Dulce underground base.was found dead January 1996, due to what appears to be an execution style murder. He was found dead in his apartment with a piano wire wrapped around his neck. According to sources, it appeared that he repeatedly suffered torture before he was finally killed. Seven months prior to his death , Schneider did a lecture on the forces he had discovered at Dulce. This brave man #39;s final acts should not go unnoticed.......................... A joint alien/US military underground base exists, perhaps devoted to genetics. The theories regarding Dulce sometimes state that alien technology was traded for permission to engage in human and animal mutilations. A battle was said to have taken place there between aliens and humans, though the time of this alleged encounter varies from the 1970s to the 1980s. Some sources allege that horrific genetic experiments are conducted in lower levels of the facility (usually level 6 or 7, depending on the source); these levels are sometimes referred to as "Nightmare Hall." According to the legend, Project Aquarius (1966) was a plan for investigation of UFOs, carried out and funded by the CIA. Bishop (Bishop, 2005) notes that Bennewitz is the earliest source for the Project Aquarius tale. This project was slated to begin after December 1969 ...From:WhitesxicanViews:0 0ratingsTime:01:10:58More inEducation

See the rest here:
The Man That Killed 2 Alien Greys (Phil Schneider) - Video

Recommendation and review posted by Bethany Smith

BOTHELL, Wash.--(BUSINESS WIRE)--

Seattle Genetics, Inc. (SGEN) today announced that more than a dozen abstracts, in addition to several collaborator abstracts, for both ADCETRIS (brentuximab vedotin) and investigational antibody-drug conjugates (ADCs) will be presented at the American Society of Hematology (ASH) Annual Meeting taking place in Atlanta, Georgia, December 8 11, 2012. ADCETRIS is an ADC directed to CD30, which is known to be expressed in Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL), as well as in some types of cutaneous T-cell lymphoma (CTCL), B-cell lymphomas and mature T-cell lymphomas (MTCL). Seattle Genetics is broadly evaluating CD30 expression in many other cancer types. ADCETRIS is currently not approved for use in CTCL, B-cell lymphomas, and front-line treatment of HL or MTCL.

"The comprehensive data presented at ASH 2012 support our goal to establish ADCETRIS as the foundation of therapy for a broad array of CD30-positive malignancies and redefine therapy in the front-line setting of HL and MTCL, said Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. "As a pioneer in developing ADC therapies, we continue to innovate by expanding the ADCETRIS program into CD30-positive malignancies, advancing additional ADC pipeline candidates, and supporting the progress of our collaborator ADC programs. These important advances represent our continued innovation and ADC leadership position."

Seattle Genetics is the leader in developing ADCs, a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. Of the approximately 30 ADC candidates currently in development, more than half utilize Seattle Genetics proprietary ADC technology. Multiple company, investigator and collaborator presentations will be presented at ASH, including data on ADCETRIS in many types of CD30-positive malignancies and preclinical data from a new ADC product candidate called SGN-CD33A. Abstract presentations planned at ASH can be found at http://www.hematology.org and include the following:

ADCETRIS Data in the Front-line Setting

ADCETRIS Data in CTCL

ADCETRIS Data in Hodgkin and Non-Hodgkin Lymphomas

Data on Other ADC Candidates and Collaborator Programs

About ADCETRIS

ADCETRIS (brentuximab vedotin) is an ADC comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics proprietary technology. The ADC employs a linker system that is designed to be stable in the bloodstream but to release MMAE upon internalization into CD30-expressing tumor cells.

View original post here:
Seattle Genetics’ ASH 2012 Presentations Highlight ADCETRIS® and Demonstrate Leadership in the Development of Antibody ...

Recommendation and review posted by Bethany Smith

Govt. Appoints Task Force To Explore Stem Cell Research
Minister of Health Hon. Dr. Perry Gomez announced that the government has appointed a 10 member task force, charged with making recommendations to the government to explore stem cell therapy in The Bahamas.From:ZNSNetworkViews:44 0ratingsTime:03:27More inNews Politics

View post:
Govt. Appoints Task Force To Explore Stem Cell Research - Video

Recommendation and review posted by simmons

123Triad : wwmsbiologicscom
123Triad is proud to design website for http://www.wwmsbiologics.com WorldWide Medical Services Inc. is a company that for more than 10 years is dedicated to utilizing the most innovative technologies to provide its clients with the highest quality services. Worldwide Medical Services specializes in the Intra-operative treatment of surgical patients. One of their most exciting new products is platelet gel and adult stem cell therapy services which can be provided in a hospital or office setting. their Autotransfusion service is available 24/7 on a scheduled or emergency basis.From:123triadcoViews:7 0ratingsTime:00:36More inScience Technology

View original post here:
123Triad : wwmsbiologicscom - Video

Recommendation and review posted by simmons

CombiCult Workflow
A overview on how Plasticell (www.plasticell.co.uk) uses combinatorial cell culture (CombiCult) to discover optimised stem cell differentiation protocols in record time, at a fraction of the cost of the status quo while reducing project return risk. CombiCult is used by our customers in a range of applications in regenerative medicine, cell therapy and research and development.From:PlasticellLimitedViews:1 0ratingsTime:06:40More inScience Technology

Read more from the original source:
CombiCult® Workflow - Video

Recommendation and review posted by simmons

blood bank | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com Umbilical cord blood is stored immediately after delivery, when the cord is cut. Diseases that are genetically based would most likely be an allogenic transplant. Human umbilical cord blood cells are very rich in stem cells and progenitor cells which make them the perfect place to take cells from and then store them in a cord blood bank or a stem cells bank. Scientists have found that umbilical blood can actually help to treat many types of medical issues. To make a long story short, the Adult Stem Cells did the trick. This would be a significant event, which would save thousands of lives of those waiting for an organ. Why would someone opt for cord blood preservation? Well, research is continually being conducted and cells extracted from this blood has already been used to treat and cure injuries and diseases. Cord Blood Banking facilities are places where you can bank your child #39;s cord blood and use it later on in life to cure life-threatening diseases. The National Cord Blood Program staff at the New York Blood Center performs cord blood collection from the expelled placenta. Because of this amazing capacity of blood cells, they have been, still are and will continue to be used more and more to save lives and cure a number of diseases. ""Umbilical cord blood contains blood-forming cells that can be used to treat life-threatening diseases and conditions. Stem cells, researchers discovered, could cure many diseases such as leukemia and ...From:hotelesenMelgarViews:0 0ratingsTime:01:18More inScience Technology

Originally posted here:
blood bank | The Development of Umbilical Cord Blood Stem Cell Therapy - Video

Recommendation and review posted by simmons

Stem Cells | Stem Cell Malaysia
stemcellmalaysia.com Stem cells are cells which have the potential to develop into virtually any cells of the body. The characteristics of stem cells render them great possibility in treating illness as well as health rejuvenation. Stem cells can repair and renew damaged cells as well as replace the dead ones so that a damaged organ or tissue can be healed to its healthy state. Visit Stem Cell Malaysia at http:/stemcellmalaysia.com/ for more information on stem cells and stem cell therapy.From:stemcells2012Views:262 2ratingsTime:06:33More inHowto Style

The rest is here:
Stem Cells | Stem Cell Malaysia - Video

Recommendation and review posted by simmons

Progenitor Cell Therapy For Neurological Injury
ll4.me Progenitor Cell Therapy For Neurological Injury Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4. Neural Stem Cells-Endogenous Repair of Neurological Injury.- Chapter 5. Traumatic Brain Injury: Pathophysiology and Models.- Chapter 6. Traumatic Brain Injury: Relationship of Clinical Injury to Progenitor Cell Therapeutics.- Chapter 7. Cell-Based Therapy for Stroke.- Chapter 8. Spinal Cord Injury: Pathophysiology and Progenitor Cell Therapy.- Chapter 9. Current Status of Clinical Trials using Progenitor Cells for Neurological Injury EAN/ISBN : 9781607619659 Publisher(s): Springer, Berlin, Springer Science Business Media Discussed keywords: Neurologie, Zelltherapie Format: ePub/PDF Author(s): Cox, Charles S. Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4From:dorethacopeland98549Views:0 0ratingsTime:00:14More inPeople Blogs

View original post here:
Progenitor Cell Therapy For Neurological Injury - Video

Recommendation and review posted by simmons

25 Multiple Sclerosis Plr Articles
ll4.me 25 Multiple Sclerosis Plr Articles 25 Multiple Sclerosis Articles - Private Label Rights Article Topics:- Treatment For Multiple Sclerosis With No Side Effects Types Of Multiple Sclerosis What Multiple Sclerotic People Should Avoid during Christmas How To Diagnose Multiple Sclerosis How To Know If It Is A Multiple Sclerosis Relapse How To Treat Multiple Sclerosis Is Cannabis Use Beneficial For Multiple Sclerosis Lifesaving Drug For Multiple Sclerosis More Information On Multiple Sclerosis Multiple Sclerosis Association Of America All About Multiple Sclerosis Causes Of Multiple Sclerosis Childbirth May Slow Multiple Sclerosis Common Human Bacteria Triggers Multiple Sclerosis Good News On Pregnancy And Multiple Sclerosis How Is Multiple Sclerosis Classified The Clinical Part Of Multiple Sclerosis The History Of Multiple Sclerosis The Kurtzke Expanded Disability Status Scale And Multiple Sclerosis Multiple Sclerosis Differential Diagnoses Not Everyone With Multiple Sclerosis Is On Treatment Pathophysiology Of Multiple Sclerosis Stem Cell Therapy Reverses Multiple Sclerosis Symptoms Of Multiple Sclerosis Teenage Obesity and Multiple Sclerosis Use the content on : Blogs/Content Pages Report Social Sites ecourses Convert to Audios ebook Bundle and Sell as Products Personal Education, Tips Training Whatever you might imagine... RIGHTS:- [YES] Can Be Sold [YES] Can Be Packaged [YES] Can Be Offered As a Bonus [YES] Can Be Added As Web Content [YES] Can Be Used For Product ...From:rebeccahenson9854Views:0 0ratingsTime:00:14More inPeople Blogs

Excerpt from:
25 Multiple Sclerosis Plr Articles - Video

Recommendation and review posted by simmons

Stem Cell Research and TNG
How close is Science to providing visors for the blind? Or what about curing blindness? Have you watched the episode "The Masterpiece Society" from season 5 of TNG? Cause I have a couple of philosophical things to say about that! An article about STEM CELL therapy in regards to vision impairment: abcnews.go.com Interview with TrekMate: http://www.trekmate.org.uk ***I feel like the Star Trek community is a lot bigger then what YouTube has to offer, so I #39;ve started uploading my own videos. A lot of you will find this painfully dorky -and it is- which is why constructive criticism is welcomed. For anyone who does like my posts, thank you! It would be nice to gather a little Trekkie community :)***From:ThatTrekkieGirlViews:6 1ratingsTime:06:51More inPeople Blogs

Read more here:
Stem Cell Research and TNG - Video

Recommendation and review posted by simmons

Charles - USA Stem Cells Testimonial
If you would like more information please call us Toll Free at 877-578-7908. Or visit our website at http://www.usastemcells.com Or click here to have a Free Phone Constultation with Dr. Matthew Burks usastemcells.com Real patient testimonials for USA Stem Cells. Adult stem cell therapy for COPD, Emphysema, and Pulmonary fibrosis.From:USAStemcellsViews:4 0ratingsTime:10:04More inScience Technology

See more here:
Charles - USA Stem Cells Testimonial - Video

Recommendation and review posted by simmons

Thelma before Stem Cell Therapy
From:krazykp12Views:2 0ratingsTime:01:33More inPeople Blogs

Excerpt from:
Thelma before Stem Cell Therapy - Video

Recommendation and review posted by simmons

SHIMMIAN MANILA - Celebs share good effects of stem cell therapy
From:myrenovatiosolutionsViews:1 0ratingsTime:01:30More inEntertainment

See the original post here:
SHIMMIAN MANILA - Celebs share good effects of stem cell therapy - Video

Recommendation and review posted by simmons

Published on 10 November 2012 Hits: 133 Written by Jovee Marie N. Dela Cruz

The Department of Health (DOH) on Friday said that it has become necessary to issue regulations for stem cell therapy in the country. Health Secretary Enrique Ona said that guidelines for clinics offering stem cell therapy will be released immediately by the DOH and the Food and Drug Administration.

We will issue guidelines because here in the country we dont know where the stem cell offered by clinics come from, he said.

According to the DOH, stem cell therapy belongs to the category of advanced cell therapy, which includes biologics and blood. Many countries apply a risk-based approach to assess the quality, efficacy and safety of advanced cell therapy.

In many countries, stem cell is considered an investigational intervention, Ona said.

The DOH said that stem cell research employs both autologous (from same person) or allogenic (from another organism like an animal or another human cell or tissue sample) method.

Ona said that because there are many steps in the preparation of this lab and invasive procedure, there is a need to have a regulatory framework to protect Filipino citizens.

Read more here:
DOH to regulate stem cell therapy in PH

Recommendation and review posted by simmons

UPDATE on Stem Cell Therapy

7 November 2012

The Department of Health (DOH) saw the necessity to cover regulations for Stem Cell therapy. Stem Cell therapy belongs to the category of Advanced Cell therapy which includes biologics and blood. Many countries around the world apply a risk-based approach to assess the quality, efficacy and safety of advanced cell therapy. In many countries, Stem Cell is considered an investigational intervention.

Stem Cell research employs both autologous (from same person) or allogenic (from another organism like animal or another human cell or tissue sample) method. Because there are many steps in the preparation of this lab and invasive procedure, there is therefore need to have a regulatory framework to protect Filipino citizens.

Important questions were asked: is there proof of concept in animal trials where stem cell can then be applied in humans? Is there a way to ensure quality and purity of the raw materials? How safe is the procedure? How many did not benefit from the procedure? If this were investigational procedure, how will human subjects be protected?

Sec. Enrique Ona convened a consultative working task force to provide recommendations on how to proceed in the early part of the year in response to queries and mushrooming of centers here and overseas. This led to the creation of a regulatory task force to oversee the appropriate steps that will ensure quality, efficacy and safety documentation of this intervention.

Visit link:
UPDATE on Stem Cell Therapy 7 November 2012

Recommendation and review posted by simmons

Whole Genome Sequencing and You
This video is about whole genome sequencing. What is a genome? What are the basics of how whole genome sequencing works? What can you find out about yourself from getting your genome sequenced? And what are the potential benefits and risks? You might be considering getting your genome sequenced for clinical, research or personal reasons. Or you might just be curious and want to learn a bit more about this technology. This video was developed to help you understand a bit more about what whole genome sequencing is, and what it could mean for you. It was developed by researchers at Mount Sinai #39;s Department of Genetics and Genomic Sciences and Department of Emergency Medicine with funding from the Charles Bronfman Institute for Personalized Medicine, with valuable input from several community consultants, patients and others from around the Mount Sinai community. bull; Visit the Department of Genetics and Genomic Sciences: ow.ly bull; Visit the Department of Emergency Medicine: ow.ly bull; Visit the Charles Bronfman Institute for Personalized Medicine: ow.lyFrom:MountSinaiSchoolViews:171 4ratingsTime:10:41More inEducation

See original here:
Whole Genome Sequencing and You - Video

Recommendation and review posted by sam

Computational Challenges and Opportunities in Personalized Medicine
Rapid progress in systems biology and molecular analytical platforms offers the promise of major gains in the detection, treatment and prevention of diseases and for targeting therapeutic interventions to match the molecular and pharmacogenetic profiles of individual patients (personalized medicine). Whole genome sequencing and other molecular diagnostics, next-generation body imaging and miniaturized on-body:in-body sensors will assume increasing importance in the healthcare value chain as powerful platforms for precision diagnosis, selection of optimum treatment, treatment compliance and remote monitoring of individual health status.From:INFORMSonlineViews:4 0ratingsTime:52:39More inScience Technology

Read the original here:
Computational Challenges and Opportunities in Personalized Medicine - Video

Recommendation and review posted by sam

CBI Project Final
Executive summary of Cascade Biotherapeutic, Inc (CBI) product and service offerings to the consumers of healthcare information applyting personalized medicine to managing their health and wellbeing, and government agencies procuring supply chain management solutions for medical countermeasures.From:jcbioteckViews:2 0ratingsTime:03:24More inScience Technology

See the original post here:
CBI Project Final - Video

Recommendation and review posted by sam

CAMBRIDGE, Mass., BOSTON and NEW YORK, Nov. 8, 2012 /PRNewswire/ --GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute (Dana-Farber) and Mount Sinai School of Medicine (Mount Sinai) to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S. that constitutes approximately one percent of all cancers. Created using GNS's supercomputer-driven REFS (Reverse Engineering and Forward Simulation) platform, the models will be used to help researchers discover novel therapies for the disease and to help determine the best existing treatments for patients.

"We have made encouraging progress at Dana-Farber Cancer Institute in using gene profiling, proteomic and signaling studies in tumor cell samples treated with existing and novel medicines to get a better understanding of myeloma pathogenesis and to develop novel targeted therapies," said Dr. Ken Anderson, Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Kraft Family Professor of Medicine at Dana-Farber and Harvard Medical School.

"Because of this progress, our team is excited about deploying a powerful, supercomputer driven approach using our multi-layered genomic data to develop computer models to directly define the integrated underlying circuitry of myeloma. We look forward to using these models to identify, create, and implement better treatments for individual multiple myeloma patients," said Dr. Nikhil Munshi, Associate Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Associate Professor of Medicine, Harvard Medical School.

"GNS will apply its Big Data analytics platform to create a disease-specific computer model that will yield a powerful new resource to the multiple myeloma research and clinical communitywith the ultimate aim of better outcomes for patients," said GNS CEO and co-founder Colin Hill. "This collaboration with Dana-Farber and Mount Sinai will create models that will help transform the tremendous amount of data coming from new technologies, such as next-generation sequencing, into predictive computer models of disease progression and treatment response for scientists and clinicians. This project is one of many examples of our work in challenging, complex and, sometimes rare, diseases."

In this collaboration, GNS will employ the REFSplatform to reverse engineer network models from next-generation genetic sequencing, proteomic, outcomes and other clinical data. Results from millions ofin silico simulations of the REFS models will provide new insights into the fundamental mechanisms of multiple myeloma, enabling the identification of novel intervention points in the disease for specific groups of patients and the development of more effective medicines.

"Prior published work has shown us that approaches like the REFS platform can develop integrated network models of disease that can be used to uncover novel drivers of disease," said Dr. Eric Schadt, Director of the Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences and the Jean C. and James W. Crystal Professor of Genomics at Mount Sinai. "With the wealth of detailed biological data available in this project, we look forward to a close collaboration with GNS to build a predictive model to elucidate novel insights into this complex disease."

About Multiple Myeloma

Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. Most cases of myeloma also feature the production of a paraproteinan abnormal antibody which can cause kidney problems. Bone lesions and hypercalcemia (high calcium levels) are also often encountered. Myeloma is diagnosed with blood tests (serum protein electrophoresis, serum free kappa/lambda light chain assay), bone marrow examination, urine protein electrophoresis and X-rays of commonly involved bones. Myeloma is generally thought to be treatable but incurable. Remissions may be induced with steroids, chemotherapy, proteasome inhibitors (e.g. bortezomib), immunomodulatory drugs (IMiDs) such as thalidomide or lenalidomide and stem cell transplants. Radiation therapy is sometimes used to reduce pain from bone lesions. Myeloma develops in 1-4 per 100,000 people per year. It is more common in men, and for unknown reasons is twice as common in African-Americans as it is in white Americans. With conventional treatment, median survival is 3-4 years, which may be extended to 5-7 years or longer with advanced treatments. Multiple myeloma is the second most common hematological malignancy in the U.S. (after non-Hodgkin lymphoma) and constitutes 1 percent of all cancers.

About REFS

REFS (Reverse Engineering and Forward Simulation) is GNS Healthcare's scalable, supercomputer-enabled framework for discovering new knowledge directly from data. REFS automates the discovery and extraction of causal network models from observational data and uses high-throughput simulations to generate new knowledge.

See the original post here:
GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma

Recommendation and review posted by sam

Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, will present two of its scientific research studies during the American College of Rheumatology (ACR) Annual Meeting, Nov. 10 to 14, in Washington DC. Both presentations reflect Ignytas scientific emphasis on epigenetic mechanisms of autoimmune diseases.

San Diego, CA (PRWEB) November 09, 2012

An oral presentation entitled The DNA Methylation Signature in Fibroblast-Like Synoviocytes (FLS) Defines Critical Pathogenic Pathways in Rheumatoid Arthritis (RA), will be delivered on Monday, Nov.12 at 2:30 p.m. by Gary Firestein, M.D., Director of the Clinical and Translational Research Institute, Dean and Associate Vice Chancellor of Translational Medicine at UCSD, and Ignyta co-founder. Ignyta scientists are listed as co-authors on the presentation.

Ignytas Chief Scientific Officer, David Anderson, Ph.D., will present a poster entitled "The DNA Methylome of Systemic Lupus Erythematosus (SLE) From Whole Peripheral Blood Mononuclear Cells (PBMCs)," during the session on Systemic Lupus Erythematosus - Human Etiology and Pathogenesis, on Tuesday, Nov. 13 from 9 a.m. - 6 p.m.

The selection by ACR of two Ignyta presentations reflects the importance of the work that Ignyta is contributing to the rheumatology field, said Jonathan Lim, M.D., CEO of Ignyta, Inc. Ignyta continues to make rapid progress in advancing novel biomarkers and molecular diagnostics for rheumatoid arthritis and systemic lupus erythematosus.

The Ignyta poster will be available for download on Monday, Nov. 12 at http://ignyta.com/nexdx_scientific_presentations.php.

Both presentations reflect Ignytas scientific emphasis on epigenetic mechanisms. Within cells, the DNA signatures caused by methylation, a dominant epigenetic regulator, are potentially a novel and important source of biomarkers to better diagnose RA and other autoimmune diseases for the following reasons:

Epigenetic mechanisms recently have been shown to have a significant impact on several human diseases, including RA and systemic lupus erythematosus. Because aberrant DNA methylation might play an important role in the pathogenesis of RA, DNA methylation signatures could be developed as a valuable diagnostic tool.

These signatures are a more chemically and biologically stable source of molecular diagnostic information than RNA and many proteins, and reflect past environmental conditions leading to persistent changes in how cells transcribe their genome, leading to the expression of genes and their protein products.

The prevalence of DNA methylation biomarkers is higher than most genetic markers of disease and can be associated with multiple sites within a cell, potentially affecting several genes or other regulatory molecules. These biomarkers can be detected with very high sensitivity and specificity in blood-based tests, serving as tools for diagnosing diseases, as well as assessing patients' prognoses and personalized responses to therapy.

The rest is here:
Ignyta Announces Scientific Presentations at American College of Rheumatology 2012 Annual Meeting

Recommendation and review posted by sam

CHALFONT, Pa., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company for neuropsychiatry, is excited to announce that company representatives will be attending and exhibiting at the American Psychiatric Nurses Association Annual Conference and the U.S. Psychiatric and Mental Health Congress, two respected conventions of mental health professionals that will occur this week.

Genomind will be on hand to share the most recent research and advancements in the field of personalized medicine, including their groundbreaking GeneceptTM Assay, a saliva-based test that quickly identifies biomarkers and genes that may influence or assist a clinician in developing a treatment plan for patients with depression and other neurological disorders. Genomind staff will share information with attendees on how such tests can be implemented into their practices, as well as how use of the test can often lead to better patient outcomes.

The American Psychiatric Nurses Association Annual Conference runs from November 7-10, 2012, at the David L. Lawrence Convention Center in Pittsburgh. The U.S. Psychiatric and Mental Health Congress will take place November 8-11, 2012, at the San Diego Convention Center.

About the Genecept Assay

The Genecept Assay is a comprehensive, simple-to-use tool for understanding genetic and biological markers that best inform response to different psychiatric treatments. The Assay is Genomind's core product, and contains a proprietary panel of biomarker tests, an analytic report, and a psychopharmacologist consultation. The Assay can be used for a range of psychiatric conditions including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD. For more information on the Assay, including information about the specific genes in the panel, please visit http://www.genomind.com/products/assay.

About Genomind

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients' lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research. Learn more at http://www.genomind.com.

For more information, contact:

Doreen Korba Director of Marketing 215.396.5596 Doreen.Korba@genomind.com

This information was brought to you by Cision http://www.cisionwire.com http://www.cisionwire.com/genomind/r/genomind-to-exhibit-at-two-upcoming-mental-health-conferences,c9331955

Excerpt from:
Genomind to Exhibit at Two Upcoming Mental Health Conferences

Recommendation and review posted by sam

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jm477c/personalized) has announced the addition of the "Personalized Medicine Partnering Terms and Agreements" report to their offering.

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report contains over 1500 links to online copies of actual personalized medicine deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Personalized Medicine Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to personalized medicine trends and structure of deals entered into by leading companies worldwide.

Personalized Medicine Partnering Terms and Agreements includes:

See the article here:
Research and Markets: Personalized Medicine Partnering Terms and Agreements

Recommendation and review posted by sam

God of AfricaBluewale Creations xvid
Grace Jerry is a sensational multi talented Gospel singer based in Jos. Despite an accident that caused her a spinal cord injury and has forced her to use a wheel chair for some years now, she has not allowed that to diminish her passion and love for God and for music. She flies her wings of creativity and music in diverse ways, she #39;s a WASH Ambassador with Water Aid, Motivational Speaker, Mentor, Life Coach and Children Teacher.From:bluewalecreationsViews:2 0ratingsTime:14:11More inEntertainment

Read the original:
God of AfricaBluewale Creations xvid - Video

Recommendation and review posted by sam